Cargando…

OC-01 Venous thromboembolic events during the first and second waves of Covid-19 in breast cancer patients treated in an outpatient day hospital

Detalles Bibliográficos
Autores principales:	Illarramendi, J., Modesto, J.L., Salgado, E., De la Cruz, S., Illarramendi, J.J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Oral Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057536/ http://dx.doi.org/10.1016/S0049-3848(21)00143-2

Ejemplares similares

MO22-2 Thromboembolic events associated to COVID-19 in a breast cancer cohort during the most recent waves of the disease
por: Illarramendi, Jorge, et al.
Publicado: (2022)

OC-02 Khorana risk score at diagnosis of SARS-CoV-2 infection as a predicting tool for venous thromboembolic disease development, and overall mortality, in cancer patients
por: López Jiménez, C., et al.
Publicado: (2021)

PO-21 Incidence of venous thromboembolism events in outpatients with cancer and COVID-19.
por: Gutiérrez Ortiz de la Tabla, A., et al.
Publicado: (2021)

OC.01.3 NON-VARICEAL UPPER GASTROINTESTINAL BLEEDING HOSPITALIZATION DURING THE FIRST PHASE OF THE COVID-19 PANDEMIC IN VENETO REGION
por: Germana”, B., et al.
Publicado: (2021)

Evaluation of the occurrence of venous thromboembolic events in COVID-19 outpatients
por: Halima, A. Ben, et al.
Publicado: (2023)

S308: RISK FACTORS FOR VENOUS THROMBOEMBOLISM IN ACUTE PROMYELOCYTIC LEUKEMIA
por: Sabljic, Nikica, et al.
Publicado: (2023)

OC.06.3 POST-COVID-19 IRRITABLE BOWEL SYNDROME
por: Marasco, G., et al.
Publicado: (2023)

A promising whole-blood biomarker to aid Leprosy control
por: Illarramendi, Ximena
Publicado: (2021)

The risk of a second cancer after hospitalisation for venous thromboembolism
por: Sørensen, H T, et al.
Publicado: (2005)

Epidemiology of Venous Thromboembolism After Second Cancer
por: Gade, Inger Lise, et al.
Publicado: (2020)

OC.07.4 RAFOXANIDE INDUCES IMMUNOGENIC DEATH OF COLORECTAL CANCER CELLS
por: Di Grazia, A., et al.
Publicado: (2021)

OC.08.1 THE IMPACT OF THE COVID-19 PANDEMIC ON HOSPITALIZATIONS FOR DIVERTICULAR DISEASE
por: Germana’, B., et al.
Publicado: (2022)

OA01.01. Role of Shwetashankhapushpi (Clitoria ternatea) and clinical yoga techniques in the management of generalized anxiety disorder
por: Chavan, Prashant J.
Publicado: (2012)

OC.02.9 IMPACT OF COVID-19 OUTBREAK ON GASTRO-INTESTINAL CANCER BURDEN
por: Milluzzo, S.M., et al.
Publicado: (2021)

Venous thromboembolic events in the tofacitinib ulcerative colitis clinical development programme
por: Sandborn, William J., et al.
Publicado: (2019)

Pathways for outpatient management of venous thromboembolism in a UK centre
por: Condliffe, Robin
Publicado: (2016)

OA01.01. A case report on psoriasis
por: Supraja, R
Publicado: (2013)

OC.06.9 ASSESSMENT OF SARCOPENIA AND NUTRITIONAL STATUS IN A COHORT OF PATIENTS WITH CROHN’S DISEASE
por: Nardone, O.M., et al.
Publicado: (2021)

OC.05.6 HELICOBACTER PYLORI AND SARS-COV-2: A DANGEROUS PATHOGENETIC CORRELATION?
por: Termite, F., et al.
Publicado: (2023)

Hypertensive Complications of Pregnancy and Risk of Venous Thromboembolism
por: Scheres, Luuk J.J., et al.
Publicado: (2020)

S306: HYPERCOAGULABILITY BIOMARKERS AND THROMBIN GENERATION (TG) PREDICT VENOUS THROMBOEMBOLISM (VTE) IN METASTATIC LUNG CANCER PATIENTS
por: Gomez Rosas, Patricia, et al.
Publicado: (2023)

Challenges of defining a non-inferiority margin: a case study of non-inferiority randomized controlled trials of oral anti-thrombolytic agents for prophylaxis of venous thromboembolic events after orthopedic surgery
por: Wangge, Grace, et al.
Publicado: (2011)

Quality of Life of breast cancer patients with COVID-19 disease
por: Arraras, J.I., et al.
Publicado: (2022)

Validation of the ONKOTEV Risk Prediction Model for Venous Thromboembolism in Outpatients With Cancer
por: Cella, Chiara A., et al.
Publicado: (2023)

COVID-19 Is Associated with an Increased Risk of Venous Thromboembolism, but Not Arterial Ischemic Stroke in Hospitalized Children: A Multicenter Observational Study
por: Kumar, Riten, et al.
Publicado: (2022)

Maternal mortality and its relationship to Emergency Obstetric Care (EmOC) in a tertiary care hospital in South India
por: Dasari, Papa
Publicado: (2014)

OC.04.8 IMPACT OF COVID-19 PANDEMIC ON REFERRAL OF PATIENTS WITH LIVER DISEASE TO A LIVER TRANSPLANT CENTER
por: Germani, G., et al.
Publicado: (2021)

OC.02.2 REDUCED EXPRESSION OF SARS-COV-2 INFECTION-RELATED GENES IN INFLAMMATORY BOWEL DISEASE PATIENTS
por: Pisani, L.F., et al.
Publicado: (2022)

OC.14.1 SARS-COV-2 INFECTION DOES NOT WORSEN THE COURSE OF INFLAMMATORY BOWEL DISEASE IN THE LONG TERM
por: Neri, B., et al.
Publicado: (2023)

Update on the FH01 study
por: Duffy, SW
Publicado: (2006)

Testosterone Therapy, Thrombophilia, Venous Thromboembolism, and Thrombotic Events
por: Glueck, Charles J., et al.
Publicado: (2018)

OA01.04. The effectiveness and cost effectiveness of acupressure for chemotherapy-related nausea
por: Hughes, J, et al.
Publicado: (2012)

OC.04.1 HIGH LEVELS OF TRANSAMINASES AT ADMISSION PREDICT A SEVERE DISEASE COURSE IN COVID-19 HOSPITALIZED PATIENTS
por: Pelizzaro, F., et al.
Publicado: (2021)

Cirrhosis is Associated with an Increased 30-Day Mortality After Venous Thromboembolism
por: Søgaard, Kirstine Kobberøe, et al.
Publicado: (2015)

Thirty-day readmissions due to Venous thromboembolism in patients discharged with syncope
por: Siddappa Malleshappa, Sudeep K., et al.
Publicado: (2020)

44. ASSOCIATION BETWEEN VENOUS THROMBOEMBOLISM RATES AND DIFFERENT PROPHYLACTIC ANTICOAGULATION REGIMENS IN PATIENTS UNDERGOING FREE FLAP RECONSTRUCTION OF THE HEAD AND NECK REGION
por: Saadoun, Rakan, et al.
Publicado: (2022)

In-hospital fatality and venous thromboembolism during the first and second COVID-19 waves at a center opting for standard-dose thromboprophylaxis
por: Mumoli, Nicola, et al.
Publicado: (2021)

OC.06.7 LOWER INCIDENCE OF COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH NON-GUT SELECTIVE BIOLOGIC THERAPY
por: Ferretti, F., et al.
Publicado: (2021)

OC.06.8 THE EMERGING ROLE OF TELEMEDICINE IN GASTROENTEROLOGY DURING THE COVID-19 PANDEMIC: A STUDY ON ITS FEASIBILITY AND PATIENTS’ TRUST
por: Costantino, A., et al.
Publicado: (2021)

OC.02.1 SAFETY OF COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA OF A NATIONAL STUDY (ESCAPE-IBD)
por: Todeschini, A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mrf518kf4p13430u7evqafee5i